TW200727903A - Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate - Google Patents

Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate

Info

Publication number
TW200727903A
TW200727903A TW095144666A TW95144666A TW200727903A TW 200727903 A TW200727903 A TW 200727903A TW 095144666 A TW095144666 A TW 095144666A TW 95144666 A TW95144666 A TW 95144666A TW 200727903 A TW200727903 A TW 200727903A
Authority
TW
Taiwan
Prior art keywords
methylenetetrahydrofolate
pharmaceutical compositions
stable pharmaceutical
citric acid
ascorbic acid
Prior art date
Application number
TW095144666A
Other languages
English (en)
Inventor
Andrew X Chen
hong-jie Wu
Mark J Cantwell
Joan M Robbins
Original Assignee
Adventrx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adventrx Pharmaceuticals Inc filed Critical Adventrx Pharmaceuticals Inc
Publication of TW200727903A publication Critical patent/TW200727903A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095144666A 2005-12-02 2006-12-01 Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate TW200727903A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74186105P 2005-12-02 2005-12-02

Publications (1)

Publication Number Publication Date
TW200727903A true TW200727903A (en) 2007-08-01

Family

ID=38092874

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095144666A TW200727903A (en) 2005-12-02 2006-12-01 Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate

Country Status (9)

Country Link
US (1) US20090221594A1 (zh)
EP (1) EP1968551A2 (zh)
JP (1) JP2009518305A (zh)
KR (1) KR20080074201A (zh)
CN (1) CN101321518A (zh)
AU (1) AU2006320388A1 (zh)
CA (1) CA2631755A1 (zh)
TW (1) TW200727903A (zh)
WO (1) WO2007064968A2 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2617421A1 (en) 2012-01-20 2013-07-24 Isofol Medical AB Tetrahydrofolates in combination with EGFR-inhibitors in the use of treating cancer
EP2617422A1 (en) * 2012-01-20 2013-07-24 Isofol Medical AB Anti-tumor activity of reduced folates like methylene-tetrahydrofolate, tetrahydrofolate or methyl-tetrahydrofolate
US9668974B2 (en) 2012-05-10 2017-06-06 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
EP2837631A1 (en) * 2013-08-14 2015-02-18 Merck & Cie New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid
WO2018065446A1 (en) * 2016-10-05 2018-04-12 Isofol Medical Ab [6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy
WO2018065445A1 (en) * 2016-10-05 2018-04-12 Isofol Medical Ab [6r]-mthf multiple bolus administration in 5-fluorouracil based chemotherapy
EP3446703A1 (en) * 2017-08-24 2019-02-27 Isofol Medical AB 6r]-mthf multiple bolus administration in 5-fluorouracil based chemotherapy
EP3305318A1 (en) * 2016-10-05 2018-04-11 Isofol Medical AB [6r]-5,10-methylenetetrahydrofolate in 5-fluorouracil based chemotherapy
EP3446704A1 (en) 2017-08-24 2019-02-27 Isofol Medical AB [6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy
IL268439B2 (en) 2017-02-14 2024-04-01 Isofol Medical Ab Methods for increasing plasma 2'-deoxyuridine in the blood and inhibiting thymidylate synthase
CA3073127A1 (en) * 2017-08-16 2019-02-21 Merck Patent Gmbh Stable lyophilisates comprising 5,10-methylene-(6r)-tetrahydrofolic acid and a dicarboxylic acid
DK3735267T3 (da) * 2018-01-05 2022-12-12 Isofol Medical Ab Indgivelse af flere boluser af [6r]-mthf i en 5-fluorouracil-baseret kemoterapi
WO2023237484A1 (en) * 2022-06-08 2023-12-14 Merck Patent Gmbh Compositions comprising disodium 5,10-methylene-(6r)-tetrahydrofolate
WO2023237482A1 (en) 2022-06-08 2023-12-14 Merck Patent Gmbh Concentrated solutions comprising sodium 5,10-methylene-(6r)- tetrahydrofolate
WO2023237483A1 (en) * 2022-06-08 2023-12-14 Merck Patent Gmbh Concentrated solutions comprising 5,10-methylene-(6r)-tetrahydrofolic acid
WO2023237485A1 (en) * 2022-06-08 2023-12-14 Merck Patent Gmbh Stable lyophilisates comprising 5,10-methylene-(6r)-tetrahydrofolic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH697021A5 (de) * 2003-06-26 2008-03-31 Merck Eprova Ag Stabile pharmazeutische Zusammensetzungen von 5, 10-Methylentetrahydrofolat.

Also Published As

Publication number Publication date
WO2007064968A2 (en) 2007-06-07
JP2009518305A (ja) 2009-05-07
CN101321518A (zh) 2008-12-10
CA2631755A1 (en) 2007-06-07
AU2006320388A1 (en) 2007-06-07
US20090221594A1 (en) 2009-09-03
WO2007064968A3 (en) 2007-12-27
KR20080074201A (ko) 2008-08-12
EP1968551A2 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
MY143795A (en) Tetrahydropyridoindole derivatives
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
TW200700093A (en) Pharmaceutical composition for the treatment of cancer
PE20061122A1 (es) Composiciones que incluyen hierro
TN2009000137A1 (en) Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200605870A (en) Topical methadone compositions and methods for using the same
MX2007009649A (es) Derivados de meleimida, composiciones farmaceuticas y metodos para el tratamiento del cancer.
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
EP1834637A4 (en) COMPOSITION FOR THE PREVENTION / TREATMENT OF DISEASES THROUGH FREE RADICALS
TW200603746A (en) Iron sulfate based phosphate adsorbent
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
WO2007056263A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
WO2007056236A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
EA201070195A1 (ru) ПРОИЗВОДНЫЕ 1,2,3,4-ТЕТРАГИДРОПИРРОЛО [1,2-А]ПИРАЗИН-6-КАРБОКСАМИДОВ И 2,3,4,5-ТЕТРАГИДРОПИРРОЛО [1,2-a][1,4]-ДИАЗЕПИН-7-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
PT1638582E (pt) Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal
DE602006015968D1 (de) Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung
PT1718651E (pt) Derivados 7h-pirrolopirimidina
MXPA04001655A (es) Derivados de acido ascorbico, metodos de sintesis y uso farmaceutico de los mismos.
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases